Holen Sie sich die Stockscreener-App
2.24
9.27%
0.19
Handel nachbörslich:
2.25
0.010
+0.45%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt FBIO?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$2.05
Offen:
$2
24-Stunden-Volumen:
593.34K
Relative Volume:
2.64
Marktkapitalisierung:
$66.24M
Einnahmen:
$80.97M
Nettoeinkommen (Verlust:
$-78.31M
KGV:
-0.2021
EPS:
-11.0849
Netto-Cashflow:
$-129.56M
1W Leistung:
+14.29%
1M Leistung:
+18.52%
6M Leistung:
+38.27%
1J Leistung:
+12.00%
1-Tages-Spanne:
$1.9907
$2.2836
1-Wochen-Bereich:
$1.97
$2.2836
52-Wochen-Spanne:
$1.325
$2.36
Fortress Biotech Inc Stock (FBIO) Company Profile
Firmenname
Fortress Biotech Inc
Sektor
Branche
Telefon
781-652-4500
Adresse
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Vergleichen Sie FBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FBIO
Fortress Biotech Inc
|
2.24 | 66.53M | 80.97M | -78.31M | -129.56M | -11.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.46 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
598.16 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
467.55 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
663.73 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.97 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-15 | Fortgesetzt | ROTH MKM | Buy |
| 2022-08-04 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-10-02 | Eingeleitet | The Benchmark Company | Buy |
| 2019-12-18 | Eingeleitet | B. Riley FBR | Buy |
| 2018-02-28 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-07-11 | Eingeleitet | Rodman & Renshaw | Buy |
| 2017-03-22 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2016-10-03 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Fortress Biotech Inc Aktie (FBIO) Neueste Nachrichten
Journey Medical Corporation to Present at the Emerging Growth Conference - GlobeNewswire
Fortress Biotech Posts Q2 2025 Earnings Loss Amid R&D-Driven Costs; Market Reaction Remains Mixed - AInvest
Will Fortress Biotech Inc. price bounce be sustainableWeekly Trade Report & Entry Point Confirmation Alerts - Newser
Fortress Biotech Inc. stock trend outlook and recovery pathGap Down & Free High Accuracy Swing Entry Alerts - Newser
Visualizing Fortress Biotech Inc. stock with heatmapsJuly 2025 Retail & Safe Capital Investment Plans - Newser
Fortress Biotech Inc.’s volatility index tracking explainedEarnings Summary Report & Daily Stock Momentum Reports - Newser
Will Fortress Biotech Inc. rebound enough to break evenWeekly Trade Analysis & Fast Gaining Stock Reports - Newser
Is Fortress Biotech Inc. stock a value trapOil Prices & Technical Pattern Based Buy Signals - newsyoung.net
Fortress Biotech, Inc. (NASDAQ:FBIO) Could Be Riskier Than It Looks - simplywall.st
Fortress Biotech Posts Q2 2025 Loss Amid High Operating Costs; Market Response Remains Mixed - AInvest
Fortress Biotech Inc. stock prediction for this weekJuly 2025 Outlook & Weekly Setup with High ROI Potential - Newser
Will Fortress Biotech Inc. stock go up soon2025 Fundamental Recap & Reliable Intraday Trade Alerts - Newser
Multi asset correlation models including Fortress Biotech Inc.July 2025 Market Mood & Technical Pattern Recognition Alerts - Newser
Using AI based signals to follow Fortress Biotech Inc.2025 Price Momentum & High Return Stock Watch Alerts - Newser
Fortress Biotech Inc. At Critical Juncture — Bounce or BreakdownBuy Signal & Fast Moving Trade Plans - metal.it
Chart based exit strategy for Fortress Biotech Inc.2025 Investor Takeaways & Community Consensus Picks - Newser
Fortress Biotech Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
How to build a dashboard for Fortress Biotech Inc. stock2025 Earnings Impact & Fast Gaining Stock Reports - Newser
Fortress Biotech (NASDAQ:FBIO) Share Price Passes Above 200 Day Moving Average Following Weak Earnings - Defense World
What makes Fortress Biotech Inc. stock price move sharplyJuly 2025 Catalysts & Reliable Momentum Entry Alerts - Newser
Fortress Biotech Reports Q2 2025 Results, Notable Acquisitions, and FDA Approval - AInvest
Will Fortress Biotech Inc. stock split in the near futureAnalyst Downgrade & Consistent Return Strategy Ideas - Newser
Fortress Biotech 2025 Q2 Earnings Strong Revenue Growth, Narrowed Net Loss - AInvest
Heatmap Data Shows High Activity in Fortress Biotech Inc. Sector2025 Big Picture & Weekly Breakout Stock Alerts - 선데이타임즈
Fortress Biotech: Q2 Earnings Snapshot - Greenwich Time
Fortress Biotech's Q2 2025: A Strategic Triad of Monetization, Regulation, and Commercial Momentum Drives Shareholder Value - AInvest
Journey Medical’s Q2 2025: Emrosi Gains Traction - TipRanks
Fortress Biotech's Q2 2025 Results: Strategic Monetization and Pipeline Catalysts Signal Long-Term Value Creation Potential - AInvest
Fortress Biotech (FBIO) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Fortress Biotech Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewswire
Key metrics from Fortress Biotech Inc.’s quarterly data2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - Newser
Tools to assess Fortress Biotech Inc.’s risk profileQuarterly Profit Review & Low Drawdown Momentum Trade Ideas - Newser
How Fortress Biotech Inc. stock performs during market volatilityBreakout Watch & High Yield Stock Recommendations - Newser
Why Fortress Biotech Inc. stock attracts strong analyst attentionJuly 2025 Breakouts & Long Hold Capital Preservation Plans - Newser
Using Python tools to backtest Fortress Biotech Inc. strategies [Stock Surge]Trade Opportunity Analysis - Newser
Statistical indicators supporting Fortress Biotech Inc.’s strengthAI Generated Buy/Sell Signal Forecast - Newser
Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewswire
Strategies to average down on Fortress Biotech Inc.Wealth Accumulation Outlook for Safe Investors - Newser
Should you hold or exit Fortress Biotech Inc. nowDaily Equity Signal Strength Summary Report - Newser
How high can Fortress Biotech Inc. stock goSmart Entry Watchlist with Daily Analysis - Newser
Multi factor analysis applied to Fortress Biotech Inc.Free Technical Entry Strategy for Beginners - Newser
Key External Factors That Drive Fortress Biotech Inc. Stock Price MovementsRapid Trade Forecast Based on Indicators - Newser
Finanzdaten der Fortress Biotech Inc-Aktie (FBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Fortress Biotech Inc-Aktie (FBIO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN |
Sep 23 '24 |
Buy |
1.84 |
763,359 |
1,404,581 |
3,657,264 |
1.55%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):